Crossmark

Application of Neonatologist Performed Echocardiography in the assessment and management of persistent pulmonary hypertension of the newborn

Crossref DOI link: https://doi.org/10.1038/s41390-018-0082-0

Published Online: 2018-08-02

Published Print: 2018-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

de Boode, Willem P.

Singh, Yogen

Molnar, Zoltan

Schubert, Ulf

Savoia, Marilena

Sehgal, Arvind

Levy, Philip T.

McNamara, Patrick J.

El-Khuffash, Afif
License Information

Text and Data Mining valid from 2018-07-01
More Information

Article History

First Online: 2 August 2018

Competing interests

: A.E.K. is in receipt of an Irish Health Research Board Clinical Trials Network Grant (HRB CTN 2014-10) and an EU FP7/2007-2013 grant (agreement no. 260777, The HIP Trial). A.G. owned equity in Neonatal Echo Skills and has received grant support from the American Heart Association. D.V.L. is in receipt of an EU FP7/2007-2013 (agreement no. 260777 the HIP trial). E.D. received lecture fees and consulting fees from Chiesi Pharmaceutical. E.N. received grant support from Research Council of Norway and Vestfold Hospital Trust. K.B. received lecture fees from Chiesi Pharmaceutical. M.B. holds a patent, “Thermal shield for the newborn baby”. S.G. received grant support from National Institute of Health Research, Health Technology Assessment (11/92/15), UK. S.R. received lecture fees for Phillips Ultrasound and GE Ultrasound. W.P.B. has received grant support from The Netherlands Organization for Health and Development (ZonMw; grant numbers 843002622 and 843002608). Z.M. has received lecture fees from Chiesi Pharmaceutical. The remaining authors declared no competing interests.